IL4 and Alzheimer disease: Collectively, 7-ML was found to inhibit the activations of IL-4 and IgE and mast cell activation, which are major mediators of the pathogenesis and development of AD, and suppressed DNCB-induced skin barrier dysfunction in our mouse model.